Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study

Journal of the American Medical Directors Association

Volumn 15, Issue 11, 2014, Pages 812-818

  de Mauleon, Adelaide ^a,i   Sourdet, Sandrine ^a   Renom Guiteras, Anna ^b   Gillette Guyonnet, Sophie ^a   Leino Kilpi, Helena ^c   Karlsson, Staffan ^d   Bleijlevens, Michel ^e   Zabategui, Adela ^f   Saks, Kai ^g   Vellas, Bruno ^a,i   Jolley, David ^h   Soto, Maria ^a,i   Meyer, Gabriele ^b   Stephan, Astrid ^b   Guiteras, Anna Renom ^b   Sauerland, Dirk ^b   Wübker, Ansgar ^b   Bremer, Patrick ^b   Hamers, Jan ^e   Afram, Basema ^e   Beerens, Hanneke C ^e   Verbeek, Hilde ^e   Zwakhalen, Sandra M G ^e   Ruwaard, Dirk ^e   Hallberg, Ingalill Rahm ^d   Emilsson, Ulla Melin ^d   Challis, David ^h   Sutcliffe, Caroline ^h   Tucker, Sue ^h   Bowns, Ian ^h   Roe, Brenda ^h   Burns, Alistair ^h   Koskenniemi, Jaana ^c   Suhonen, Riitta ^c   Viitanen, Matti ^c   Arve, Seija ^c   Stolt, Minna ^c   Hupli, Maija ^c   Tiit, Ene Margit ^g   Leibur, Jelena ^g   Raamat, Katrin ^g   Armolik, Angelika ^g   Toivari, Teija Tuula Marjatta ^g   Zabalegui, Adelaida ^f   Navarro, Montserrat ^f   Cabrera, Esther ^f   Risco, Ester ^f   Milhet, Agathe ⁱ   Gillette, Sophie ⁱ   more..

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c UNIVERSITY OF TURKU   (Finland)

^d LUND UNIVERSITY   (Sweden)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f HOSPITAL CLÍNIC   (Spain)

^g UNIVERSITY OF TARTU   (Estonia)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Antipsychotic; Dementia; Elderly; Nursing home

Indexed keywords

NEUROLEPTIC AGENT;

AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEMENTIA; ESTONIA; EXPLORATORY RESEARCH; FEMALE; FINLAND; FRANCE; GERMANY; HUMAN; HYPERACTIVITY; INSTITUTIONAL CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NURSING HOME PATIENT; PRESCRIPTION; PSYCHOPHARMACOTHERAPY; SPAIN; SWEDEN; UNITED KINGDOM; DRUG UTILIZATION; EUROPE; NURSING HOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DEMENTIA; DRUG UTILIZATION; EUROPE; FEMALE; HUMANS; MALE; NURSING HOMES;

EID: 84908265458     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.06.015     Document Type: Article

References (36)

1. Prince M., Bryce R., Albanese E., et al. The global prevalence of dementia: A systematic review and meta-analysis. Alzheimer Dementia 2013, 9:63-75.
2. Prince M, Ferri CP, Sousa R, etal. London: Alzheimer's Disease International 2009. World Alzheimer Report2009. Available at: . Accessed August 6, 2014. http://www.alz.co.uk/research/files/WorldAlzheimerReport-ExecutiveSummary.pdf.
3. Steinberg M., Shao H., Zandi P., et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. Int J Geriatr Psychiatry 2008, 23:170-177.
4. Ballard C., Corbett A., Chitramohan R., et al. Management of agitation and aggression associated with Alzheimer's disease: Controversies and possible solutions. Curr Opin Psychiatry 2009, 22:532-540.
5. Schneider L.S., Dagerman K., Insel P.S. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006, 14:191-210.
6. Gustafsson M., Karlsson S., Lovheim H. Inappropriate long-term use of antipsychotic drugs in common amongst people with dementia living in specialised care units. BMC Pharmacol Toxicol 2013, 14:10.
7. Maher A.R., Maglione M., Baley S., et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: A systematic review and meta-analysis. JAMA 2011, 306:1359-1369.
8. Larrayadieu A., Abellan van Kan G., Piau A., et al. Associated factors with antipsychotic use in assisted living facilities: A cross-sectional study of 4367 residents. Age Ageing 2011, 40:368-375.
9. Huber M., Kolzsch M., Rapp M.A., et al. Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia. Pharmacopsychiatry 2012, 45:182-188.
10. Department of Health. The use of antipsychotic medication for people with dementia. Time for action. A report for the Minister of State for Care Services by Professor Sube Banerjee; 2009. Available at: . Accessed November 2009. http://psychrights.org/research/digest/nlps/BanerjeeReportOnGeriatricNeurolepticUse.pdf.
11. Kamble P., Chen H., Sherer J.T., et al. Use of antipsychotics among elderly nursing home residents with dementia in the US: An analysis of National Survey Data. Drugs Aging 2009, 26:483-492.
12. Verbeek H., Meyer G., Leino-Kilpi H., et al. AEuropean study investigating patterns of transition from home care towards institutional dementia care: The protocol of a RightTimePlaceCare study. BMC Public Health 2012, 12:68.
13. Folstein M.F., Folstein S.E., Mc Hugh P.R. Mini-Mental Test: A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
14. OECD The OECD Health Project. Long-term Care for Older People 2005, OECD Publishing, Paris.
15. Charlson M., Szatrowski T.P., Peterson J., et al. Validation of a combined comorbidity index. JClin Epidemiol 1994, 47:1245-1251.
16. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL. A standardized measure of biological and psychological function. JAMA 1963, 185:914-919.
17. Kaufer D.I., Cummings J.L., Ketchel P., et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. JNeuropsychiatry Clin Neurosci 2000, 12:233-239.
18. Canevelli M., Adali N., Voisin T., et al. Behavioral and psychological subsyndromes in Alzheimer's disease using the neuropsychiatric inventory. Int J Geriatr Psychiatry 2012, 28:795-803.
19. Zarit S.H., Reever K.E., Bach-Peterson J. Relatives of the impaired elderly: Correlates of feelings of burden. Gerontologist 1980, 20:649-655.
20. Alanen H.M., Finne-Soveri H., Fialova D., et al. Use of antipsychotic medications in older home-care patients: Report from nine European countries. Aging Clin Exp Res 2008, 20:260-265.
21. Lopez O.L., Becker J.T., Chang Y.F., et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry 2013, 170:1051-1058.
22. Briesacher B.A., Tjia J., Field T., et al. Antipsychotic use among nursing home residents. JAMA 2013, 309:440-442.
23. Rolland Y., Andrieu S., Crochard A., et al. Psychotropic drug consumption at admission and discharge of nursing home residents. JAm Med Dir Assoc 2012, 13:407-412.
24. Zuidema S.U., de Jonghe J.F., Verhey F.R., et al. Psychotropic drug prescription in nursing home patients with dementia: Influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr 2011, 23:1632-1639.
25. Richter T., Mann E., Meyer G., et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: A comparison of 3 cohorts. JAm Med Dir Assoc 2012, 13:187.e7-187.e13.
26. Gauthier S., Cummings J., Ballard C., et al. Management of behavioral problem in Alzheimer's disease. Int Psychogeriatr 2010, 22:346-372.
27. Rabins P.V., Blacker D., Rovner B.W., et al. APA Work Group on Alzheimer's disease and other Dementias; Steering Committee on Practice Guidelines. Am J Psych 2007, 164:5-56.
28. Lyketsos C.G., Colenda C.C., Beck C., et al. Position statement of the American Association for geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry 2006, 14:561-572.
29. Benoit M., Arbus C., Blanchard F., et al. Professional consensus on the treatment of agitation, aggressive behavior, oppositional behavior and psychotic disturbances in dementia. JNutr Health Aging 2006, 10:410-415.
30. The Medical Products Agency (MPA). Information from the Medical Products Agency 5; 2008. Drug Therapy and treatment at Behavioural and Psychological Symptoms of Dementia. Uppsala: The Medical Products Agency,2008.
31. National Board of Health and welfare Treatment using antipsychotic medication in nursing homes 2010, National Board of Health and Welfare, Stockholm.
32. Toshio N., Takeo T., Koji T., et al. Use of infrared sensor system to take long-term bedside measurements of rest-activity patterns in the elderly with dementia. Psychiatry Clin Neurosci 2002, 56:287-288.
33. Health and Social Care Information Centre. National dementia and antipsychotic prescribing. Clinical Audit Support Unit (CASU),2012.
34. Testad I., Auer S., Mittelman M., et al. Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. Int J Geriatr Psychiatry 2010, 25:725-731.
35. Richter T., Meyer G., Mohler R., et al. Psychosocial interventions for reducing antipsychotic medication in care home residents. Cochrane Database Syst Rev 2012, (12):CD008634.
36. Rosenberg P., Mielke M., Han D., et al. The association of psychotropicmedication use with the cognitive, functional, and neuropsychiatrictrajectory of Alzheimer's disease. Int J Geriatr Psychiatry 2012, 27:1248-1257.